Shares of NeoGenomics, Inc. (NASDAQ:NEO) reached a new 52-week high during trading on Thursday after Raymond James raised their price target on the stock from $16.00 to $21.00. Raymond James currently has a buy rating on the stock. NeoGenomics traded as high as $19.00 and last traded at $18.95, with a volume of 62130 shares […]


Full article